Search people, articles, bills, and more
This bill addresses a significant financial burden for individuals and families dealing with chronic respiratory conditions. Prescription inhalers are often very expensive, and high deductibles or co-pays can make it difficult for people to afford their necessary medications, leading to poor health outcomes, emergency room visits, and hospitalizations.
If this bill becomes law, people with asthma and COPD would face fewer financial barriers to accessing their essential medications and equipment, potentially leading to better management of their conditions and improved quality of life. Without this bill, patients would continue to pay potentially high costs for inhalers, including having to meet their deductible before insurance coverage begins, which can result in delaying or forgoing critical treatments.
No reactions yet. Be the first to weigh in.
This bill addresses a significant financial burden for individuals and families dealing with chronic respiratory conditions. Prescription inhalers are often very expensive, and high deductibles or co-pays can make it difficult for people to afford their necessary medications, leading to poor health outcomes, emergency room visits, and hospitalizations.
If this bill becomes law, people with asthma and COPD would face fewer financial barriers to accessing their essential medications and equipment, potentially leading to better management of their conditions and improved quality of life. Without this bill, patients would continue to pay potentially high costs for inhalers, including having to meet their deductible before insurance coverage begins, which can result in delaying or forgoing critical treatments.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)